Table 3. Systolic and diastolic blood pressure during antihypertensive treatment. SBP- systolic blood pressure; DBP-diastolic blood pressure; *-p<0.001; A-lisinopril and/or lisinopril +hydrochlorothiazide; B-losartan and/or losartan + hydrochlorothiazide; C-valsartan and/or valsartan +hydrochlorothiazide; D-lisinopril and/or lisinopril+hydrochlorothiazide and amlodipine; E-losartan and/or losartan + hydrochlorothiazide and amlodipine; F-valsartan and/or valsartan +hydrochlorothiazide and amlodipine.
| SBP (mmHg) | DBP (mmHg) | |||||||
|---|---|---|---|---|---|---|---|---|
| baseline | 2nd follow up | %Δ | ΔSBP (95%CI) mmHg | baseline | 2nd follow up | %Δ | ΔSBP (95%CI) mmHg | |
| A (N=237) | 142.5±1.1 | 130.8±1.0 | -8.8 | -11.7 (9.3-14.1)* | 87.4±0.8 | 81.8±0.7 | -6.4 | -5.5 (3.9-7.1)* |
| B(N=78) | 148.7±2.1 | 131.0±2.1 | -11.9 | -18.0 (13.6-22.4)* | 91.4±1.4 | 81.3±1.2 | -11.1 | -10.0 (6.7-13.3)* |
| C(N=180) | 151.8±1.4 | 135.3±1.2 | -10.9 | -17.3 (14.1-20.5)* | 90.4±0.9 | 83.8±0.7 | -7.3 | -6.8 (4.8-8.8)* |
| D(N=81) | 148.2±1.9 | 133.9±1.6 | -9.6 | -14.6 (10.7-17.9)* | 92.6±1.3 | 82.2±1.2 | -11.2 | -10.4 (7.6-13.2)* |
| E(N= 29) | 150.3±3.8 | 132.5±3.3 | -11.8 | -17.8 (9.6-26.0)* | 92.6±2.2 | 79.1±1.8 | -14.6 | -13.4 (7.7-19.1)* |
| F(N= 60) | 155.1±2.2 | 131.9±1.6 | -15 | -23.2 (18.3-28.1)* | 94.6±1.6 | 83.4±1.2 | -11.8 | -11.2 (7.9-14.5)* |